Byetta May Cause Cancer Risk
April 13th, 2010According to top a U.S. regulator at the Food and Drug Administration (“FDA”), Byetta, the diabetes drug manufactured by Amylin Pharmaceuticals Inc. and Eli Lilly & Co., could be linked to a an increased risk of thyroid cancer. In a memo posted on the FDA’s website, Curtis Rosenbraugh, head of the FDA’s Office of Drug Evaluation II, stated that the proposed once-weekly version of Byetta, known as Byetta LAR, appears to “give a similar signal” as cancers seen in animal testing of Novo Nordisk’s rival medication, Victoza. This memo is the first indication that the new long...
